Targeted Oncology1 天
Phase 3 PEACE-3 Study of Enzalutamide + Ra-223: Safety
Evan Y. Yu, MD, discusses the safety data from the phase 3 PEACE-3 study of enzalutamide (ENZA) combined with radium-223 ...
Targeted Oncology1 天
Phase 3 PEACE-3 Study of Enzalutamide + Ra-223: Efficacy Data
Evan Y. Yu, MD, discusses the key efficacy findings from the PEACE-3 study, which assessed the combination of enzalutamide (ENZA) and radium-223 (Ra-223) in androgen receptor pathway inhibitor ...